120 companies

Zhejiang Taimei Medical Technology

Market Cap: HK$2.1b

Zhejiang Taimei Medical Technology Co., Ltd.

2576

HK$3.73

7D

-3.4%

1Y

-25.7%

China Regenerative Medicine International

Market Cap: HK$155.2m

An investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China.

8158

HK$0.51

7D

17.2%

1Y

45.7%

Pak Fah Yeow International

Market Cap: HK$757.3m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

239

HK$2.49

7D

1.6%

1Y

2.0%

Jacobson Pharma

Market Cap: HK$2.5b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

2633

HK$1.24

7D

-3.9%

1Y

22.8%

Mirxes Holding

Market Cap: HK$13.2b

A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.

2629

HK$47.12

7D

-7.6%

1Y

n/a

TYK Medicines

Market Cap: HK$5.2b

A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.

2410

HK$13.32

7D

1.4%

1Y

-75.6%

CANbridge Pharmaceuticals

Market Cap: HK$1.0b

A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.

1228

HK$1.92

7D

-12.3%

1Y

1,206.1%

WuXi XDC Cayman

Market Cap: HK$85.3b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$70.00

7D

5.6%

1Y

118.8%

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd

Market Cap: HK$7.4b

Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.

1349

HK$2.82

7D

-2.4%

1Y

13.3%

Shandong Boan Biotechnology

Market Cap: HK$5.4b

A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.

6955

HK$8.98

7D

0.3%

1Y

2.3%

Cutia Therapeutics

Market Cap: HK$1.9b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

2487

HK$5.19

7D

-11.9%

1Y

-24.0%

AIM Vaccine

Market Cap: HK$4.2b

Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.

6660

HK$3.44

7D

-2.0%

1Y

-46.1%

Page 4 of 4